ÄûÃʵ¼º½

News

VOLUME 2 – High Fidelity? -symposium on Sound Art opens 23.11

VOLUME 2 – High Fidelity? symposium on Sound Art focuses on space and sound as artistic materials.
volumescape_en.jpg

VOLUME 2 – High Fidelity? symposium on Sound Art focuses on space and sound as artistic materials and the relation of experimental electronic music and sound art. The international presenters approach these questions from the point of view of artistic and research practice. How to talk about the quality of sound?

International keynotes, presentations, panel discussions and sound workshops: Antye Greie // Antti Ikonen // Heta Kaisto// PerMagnus Lindborg // Tony Myatt // Petteri Nisunen // Ville Pulkki // Taina Riikonen and the full program can be found .

is free of charge, no registration required. Limited number of seats.

Organizers: Aalto University School of Arts, Design and Architecture Department of Art in collaboration with Department of Media

For further information contact (professor in Aalto Univeristy Department of Art)

  • Updated:
  • Published:
Share
URL copied!

Read more news

Person in dark suit presenting ELLIS Institute Finland slide with colourful icons in a lecture room
Cooperation, Press releases, Research & Art Published:

ELLIS Institute Finland is launching machine learning fundamentals out of the lab

Research moonshots, foundation models for healthcare, and AI for RDI
Research & Art Published:

ACRIS service restored

The ACRIS research information management system is now open following the planned service break on 13–20 April 2026.
Design Methods class smiling faces during group work. Photo: Ayse Pekdiker
Research & Art Published:

Science must have a voice in society – but how?

Trust in science has fallen in Finland by almost ten percentage points in two years
The Proteins.1 team smiling at the camera. 3 men wearing dark shirts smiling at the camera
Research & Art Published:

Meet our startup: Proteins.1 aims for a breakthrough in early disease detection

Biotechnology startup Proteins.1 is developing a technology that could enable the detection of diseases such as cancer months, or even years, earlier than is currently possible. The key lies in identifying individual proteins from a blood sample.